|
|
Pre Conference Summit:
1 December 2009 9am - 5pm
Day 1
2 December 2009 9am - 5pm
Day 2
3 December 2009 9am - 5pm
Post Conference Masterclass:
4 December 2009 9am - 5pm
› Full conference programme
|
Dr Theodore Torphy,
Chief Scientific Officer & Head External Research & Early Development,
Johnson & Johnson, United States
Mr Murtaza Khorakiwala,
Managing Director,
Wockhardt, India
Dr Tsutomu Une,
Chairman of the Board,
Ranbaxy Laboratories,
Member of the Board, Senior Executive Officer of Corporate Strategy, Daiichi Sankyo, Japan
Dr M.K. Bhan,
Secretary, Ministry of Science & Technology, Department of Biotechnology,
Government of India, India
Dr Rayasam (Ray) Prasad,
Chief Operating Officer - Global (Biologics),
Biological E. Limited, India
Dr Lee E. Babiss,
President & Global Head of Research,
F. Hoffmann-La Roche, Inc, Switzerland
|

|
|
|
bioLOGIC India 2009
What's new?
- Two focused streams in biomanufacturing and R&D
- CMO and CRO showcase
- Innovative forum
- 50+ new top level speakers
- 45 Organisations represented
Event at a glance
Tuesday
1 December 2009 |
Wednesday
2 December 2009 |
Thursday
3 December 2009 |
Friday
4 December 2009 |
| Pre-conference Day |
Conference Day One |
Conference Day Two |
Post conference masterclass |
| India Innovation Forum |
Stream 1: Manufacturing |
Stream 2: R&D |
| Innovation in India |
India biologic business outlook and opportunities for global players |
Advance biomanufacturing of biosimilars |
Driving drug research and development in India |
Analytical methods for characterisation and comparability analysis of bioproducts |
| Morning refreshments |
|
| Developing new and next generation vaccines in India |
Going global: Business models and expansion strategy |
Operation, construction and engineering |
Strengthening India's competitiveness for drug discovery and development |
| Networking luncheon |
|
| Stem cells and regenerative medicines: where is India heading? |
Opportunities and challenges in the Asian and Indian biopharmaceutical industry |
Optimizing biomanufacturing capability and competency |
Cost effective clinical trials in India |
| Afternoon refreshment |
|
| Innovative gene therapy from India |
Strategies in penetrating international biosimilar business |
CMO Showcase |
CRO and Clinical Service Providers Showcase |
|
|
|
|
|
special delegate pricing for India based biopharmaceuticals
*Terrapinn reserves the right to determine eligibility to special rates.
|
|
|
|
|
|
|
|
|